CoChat

DeepDrug: A general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction

Open access
Yin, Qijin, Fan, Rui, Cao, Xusheng, Liu, Qiao, Jiang, Rui, Zeng, Wanwen · 2023 · Quantitative Biology
Cited by 56

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Computational methods for DDIs and DTIs prediction are essential for accelerating the drug discovery process. We proposed a novel deep learning method DeepDrug, to tackle these two problems within a unified framework. DeepDrug is capable of extracting comprehensive features of both drug and target protein, thus demonstrating a superior prediction performance in a series of experiments. The downstream applications show that DeepDrug is useful in facilitating drug repositioning and discovering the potential drug against specific disease. Background: Computational approaches for accurate prediction of drug interactions, such as drug‐drug interactions (DDIs) and drug‐target interactions (DTIs), are highly demanded for biochemical researchers. Despite the fact that many methods have been proposed and developed to predict DDIs and DTIs respectively, their success is still limited due to a lack of systematic evaluation of the intrinsic properties embedded in the corresponding chemical structure. Methods: In this paper, we develop DeepDrug, a deep learning framework for overcoming the above limitation by using residual graph convolutional networks (Res‐GCNs) and convolutional networks (CNNs) to learn the comprehensive structure‐ and sequence‐based representations of drugs and proteins. Results: DeepDrug outperforms state‐of‐the‐art methods in a series of systematic experiments, including binary‐class DDIs, multi‐class/multi‐label DDIs, binary‐class DTIs classification and DTIs regression tasks. Furthermore, we visualize the structural features learned by DeepDrug Res‐GCN module, which displays compatible and accordant patterns in chemical properties and drug categories, providing additional evidence to support the strong predictive power of DeepDrug. Ultimately, we apply DeepDrug to perform drug repositioning on the whole DrugBank database to discover the potential drug candidates against SARS‐CoV‐2, where 7 out of 10 top‐ranked drugs are reported to be repurposed to potentially treat coronavirus disease 2019 (COVID‐19). Conclusions: To sum up, we believe that DeepDrug is an efficient tool in accurate prediction of DDIs and DTIs and provides a promising insight in understanding the underlying mechanism of these biochemical relations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15302/j-qb-022-0320

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 56

Metadata

Authors
Yin, Q., Fan, R., Cao, X., Liu, Q., Jiang, R., & Zeng, W.
Venue
Quantitative Biology
Publisher
Wiley
Published
2023-09
Volume
11
Issue
3
Pages
260-274
ISSN
  • 2095-4689 (ISSN-L)
  • 2095-4697
OpenAlex
W4360591883
Cited by
56
References
17
FWCI
6.84
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DeepDrug: A general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction. https://app.cochat.ai/papers/10.15302/j-qb-022-0320
The paper
Yin, Q., Fan, R., Cao, X., Liu, Q., Jiang, R., & Zeng, W. (2023). DeepDrug: A general graph‐based deep learning framework for drug‐drug interactions and drug‐target interactions prediction. Quantitative Biology. https://doi.org/10.15302/j-qb-022-0320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.